neoantigen mRNA vaccine

Researcher Dr. Jeffrey S. Weber led a clinical trial that found adding a vaccine to an immunotherapy reduced melanoma recurrence. PHOTO: JULIANA THOMAS
Reducing the likelihood of melanoma recurring or causing death by 44 percent